Efbemalenograstim alfa
Term · Oncology and biomedicine · MLC-T-ONC-013219
A recombinant dimeric fusion peptide of the human granulocyte colony-stimulating factor (G-CSF; filgrastim), with immunomodulating and hematopoietic activities. Efbemalenograstim alfa binds to the cell surface G-CSF receptors (G-CSFRs) inducing receptor dimerization and activation of signaling cascades such as the Jak-STAT and mitogen-activated protein kinase pathways. This stimulates neutrophil progenitor proliferation and differentiation. Compared to other preparations of monomer recombinant G-CSF, dimeric filgrastim may allow for stronger activation of G-CSFRs and a faster myeloid precursor response thus enhancing neutrophil recovery upon myelosuppressive therapy.
| Identifier | MLC-T-ONC-013219 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | recombinant dimeric G-CSF fusion protein F627; Rh G-CSF Fc fusion protein F-627 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013219",
"term": "Efbemalenograstim alfa",
"field": "Oncology and biomedicine",
"definition": "A recombinant dimeric fusion peptide of the human granulocyte colony-stimulating factor (G-CSF; filgrastim), with immunomodulating and hematopoietic activities. Efbemalenograstim alfa binds to the cell surface G-CSF receptors (G-CSFRs) inducing receptor dimerization and activation of signaling cascades such as the Jak-STAT and mitogen-activated protein kinase pathways. This stimulates neutrophil progenitor proliferation and differentiation. Compared to other preparations of monomer recombinant G-CSF, dimeric filgrastim may allow for stronger activation of G-CSFRs and a faster myeloid precursor response thus enhancing neutrophil recovery upon myelosuppressive therapy.",
"synonyms": [
"recombinant dimeric G-CSF fusion protein F627",
"Rh G-CSF Fc fusion protein F-627"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/efbemalenograstim-alfa/"
}
Record 6,394 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.